A Phase II Study of SU011248 in Advanced Hepatocellular Carcinoma
Phase of Trial: Phase II
Latest Information Update: 17 Mar 2014
At a glance
- Drugs Sunitinib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 14 Apr 2008 Interim results were reported at AACR 2008 in the late-breaker session (abstract LB-139).
- 02 Jan 2008 Status changed from recruiting to in progress.